A cost-utility analysis of laser-assisted angioplasty for peripheral arterial occlusions

International Journal of Technology Assessment in Health Care

Volumn 12, Issue 1, 1996, Pages 104-125

  Sculpher, Mark ^a   Michaels, Jonathan ^b   McKenna, Mike ^c   Minor, Julia ^d  

^a BRUNEL UNIVERSITY   (United Kingdom)

^b Northern General Hospital NHS Trust   (United Kingdom)

^c BATTELLE MEMORIAL INSTITUTE   (United States)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOPLASTY; BIOMEDICAL TECHNOLOGY ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DECISION THEORY; EXCIMER LASER; FEMALE; GUIDE WIRE; HEALTH CARE COST; HUMAN; LASER ANGIOPLASTY; MAJOR CLINICAL STUDY; MALE; MODEL; NEODYMIUM LASER; PERIPHERAL OCCLUSIVE ARTERY DISEASE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SURVIVAL;

EID: 0029970324     PISSN: 02664623     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0266462300009430     Document Type: Review

References (56)

1. Ahn, S. S., Eton, D., & Moore, W. S. Endovascular surgery for peripheral arterial occlusive disease. Annals of Surgery, 1992, 216, 3-16.
2. Anderson, J. B., Wolinski, A. P., Wells, I. P., et al. The impact of percutaneous transluminal angioplasty on the management of peripheral vascular disease. British Journal of Surgery, 1986, 73, 17-19.
3. Ashley, S., & Keeler, R. C. Laser angioplasty. British Journal of Surgery, 1993, 80, 550-51.
4. Banta, H. D., & Schou, I. (eds.). Lasers in health care, effectiveness, cost-effectiveness and policy implications. Denmark: Academic, 1991.
5. Banta, H. D., & Vondeling, H. Strategies for successful evaluation and policy-making toward health care technology on the move: The case of medical lasers. Social Science and Medicine, 1994, 38, 1663-74.
6. Beck, J. R., & Pauker, S. G. The Markov process in medical prognosis. Medical Decision Making, 1983, 3, 419-58.
7. Brazier, J. E., Harper, R., Jones, N. M. B., et al. Validating the SF-36 health survey questionnaire: New outcome measure for primary care. British Medical Journal, 1992, 305, 160-64.
8. Briggs, A., Sculpher, M., & Buxton, M. Uncertainty in the economic evaluation of health care technologies: The role of sensitivity analysis. Health Economics, 1994, 3, 95-104.
9. Cairns, J. Discounting and health benefits: Another perspective. Health Economics, 1992, 1, 76-81.
10. Cumberland, D. C., Sanborn, T., Tayler, D. I., et al. Percutaneous laser thermal angioplasty: Initial clinical results with a laser probe in total peripheral artery occlusions. Lancet, 1986, 1457-59.
11. Dormandy, J., Mahir, M., Ascady, G., et al. Fate of patients with chronic leg ischaemia. Journal of Cardiovascular Surgery, 1989, 30, 50-57.
12. Drabaek, H., Mehlsen, J., Himmelstup, H., et al. A botanical compound, Padma 28, increases walking distance in stable intermittent claudication. Angiology, 1993, 44, 863-67.
13. Drummond, M. F., Brandt, A., Luce, B., et al. Standardizing methodologies for economic evaluation in health care. International Journal of Technology Assessment in Health Care, 1993, 9, 26-36.
14. Drummond, M. F., Stoddart, G. L., & Torrance, G. W. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press, 1987.
15. EuroQol Group. EuroQol: A new facility for the measurement of health-related quality of life. Health Policy, 1990, 16, 199-208.
16. Gerard, K. Cost-utility in practice: A policy maker's guide to the state of the art. Health Policy, 1992, 21, 249-79.
17. Hansen, D. D., Auth, D. C., Hall, M., et al. Rotational endarterectomy in normal canine coronary arteries: A preliminary report. Journal of Cardiology, 1988, 11, 1073-77.
18. H. M. Treasury. Economic appraisal in central government: A technical guide for government departments. London: HMSO, 1991.
19. Hunink, M. G. M., Wong, J. B., Donaldson, M. C., et al. Patency results of percutaneous and surgical revascularization for femoropopliteal arterial disease. Medical Decision Making, 1994, 14, 77-81.
20. Imparato, A. M., Geun-Eun, K., & Davidson, T. Intermittent claudication: Its natural course. Surgery, 1975, 78, 795-99.
21. Jeans, W. D., Armstrong, S., Cole, S. E. A., et al. Fate of patients undergoing transluminal angioplasty for lower-limb ischaemia. Interventional Radiology, 1990, 177, 559-64.
22. Jelnes, R., Gaardsting, O., Jensen, K. H., et al. Fate in intermittent claudication: Outcome and risk factors. British Medical Journal, 1986, 293, 1137-40.
23. Johnson, B. F., Evans, L., Drury, R., et al. Limb-threatening ischaemia: a reappraisal of the costs and benefits. European Journal of Vascular Disease, in press.
24. Johnston, K. W., Rae, M., Hogg-Johnston, S. A., et al. Five-year results of a prospective study of percutaneous transluminal angioplasty. Annals of Surgery, 1987, 206, 403-13.
25. Kannel, W. B., Skinner, J. J., Schwartz, M. J., et al. Intermittent claudication. Circulation, 1970, 41, 875-83.
26. Kensey, K. R., Zarins, C., Whitimore, A., et al. Dynamic angioplasty as a treatment modality in peripheral vascular disease: The first clinical results. Journal of the American College of Cardiology, 1987, 9, 180.
27. Lammer, J., Pilger, E., Decrinis, M., et al. Pulsed excimer laser versus continuous-wave Nd: YAG laser versus conventional angioplasty of peripheral arterial occlusions: Prospective randomized controlled trial. Lancet, 1992, 340, 1183-88.
28. Laupacis, A., Feeny, D., Detsky, A. S., et al. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. Canadian Medical Association Journal, 1992, 146, 473-81.
29. Maynard, A. Developing the health care market. Economic Journal, 1991, 101, 1277-86.
30. McDaniel, M. D., & Cronenwett, J. L. Basic data related to the natural history of intermittent claudication. Annals of Vascular Surgery, 1989, 3, 273-77.
31. Mehlsen, J., Himmelstup, H., Himmelstup, B., et al. Beneficial effects of intermittent suction and pressure treatment in intermittent claudication. Angiology, 1993, 44, 16-20.
32. Michaels, J. A. Percutaneous arterial recanalization. British Journal of Surgery, 1990, 77, 373-79.
33. Michaels, J. A., Browse, D. J., McWhinnie, D. L., et al. The provision of vascular surgical services in the Oxford region. British Journal of Surgery, 1994, 81, 377-81.
34. Miller, D. K., & Homan, S. M. Determining transition probabilities: Confusion and suggestions. Medical Decision Making, 1994, 14, 52-58.
35. Mohide, E. A., Torrance, G. W., Streiner, D. L., et al. Measuring the well-being of family caregivers using the time trade-off technique. Journal of Clinical Epidemiology, 1988, 41, 475-82.
36. Murray, A., Wood, R. F. M., Mitchell, D. C., et al. Peripheral laser angioplasty with pulsed dye laser and ball-tipped optical fibres. Lancet, 1989, 1471-74.
37. Neilson, S., Robinson, I., & Hunter, M. Static and dynamic models of interdiseasecompetition: Past and projected mortality from amyotrophic lateral sclerosis and multiple sclerosis. Mechanisms of Ageing and Development, 1993, 66, 223-41.
38. Nord, E. The validity of a visual analogue scale in determining social utility weights for health states. International Journal of Health Planning and Management, 1991, 6, 234-42.
39. Norgren, L. Definition, incidence, and epidemiology. In J. A. Dormandy and G. Stock (eds.), Critical leg ischaemia: Its pathophysiology and management. Berlin: Springer-Verlag, 1990.
40. Parsonage, M., & Neuberger, H. Discounting and health benefits. Health Economics, 1992, 1, 71-79.
41. Rienks, R., & Borst, C. Treatment of atherosclerotic cardiovascular disease: Effectiveness. In D. Banta and I. Schou, (eds.), Laser in health care: Effectiveness, cost-effectiveness and policy implications. Denmark: Academic, 1991.
42. Riggs, J. E., & Michecchia, R. J. Mortality among the elderly in the U.S. 1956-87: Demonstration of the upper boundary to Gompertzian mortality. Mechanisms of Ageing and Development, 1992, 62, 191-99.
43. Sanborn, T. A., Cumberland, D. C., Greenfield, A. J., et al. Percutaneous laser thermal angioplasty: Initial results and 1-year follow-up in 129 femoropopliteal lesions. Radiology, 1988, 168, 121-25.
44. Schieber, G. J., & Poullier, J. P. Overview of international comparisons of health care expenditures. Health Care Financing Review, 1989, annual supplement, 1-7.
45. Sculpher, M. J. Final Report of the Phase II Medical Laser Technology Assessment, Uxbridge: Brunel University, HERG Research Report No. 18, 1994.
46. Sculpher, M. J., & Buxton, M. J. Report of Phase I of the Medical Laser Technology Assessment. Uxbridge: Brunel University, HERG Research Report No. 9, 1991.
47. Simpson, J. B., Selmon, M. R., Robertson, G. C., et al. Transluminal atherectomy for occlusive peripheral vascular disease. American Journal of Cardiology, 61, 96G-101G.
48. Sonnenberg, F. A., & Beck, J. R. Markov models in medical decision making. Medical Decision Making, 1993, 13, 322-38.
49. Stewart, C. P., Jain, A. S., & Ogston, S. A. Lower limb amputee survival. Prosthetics and Orthotics Information, 1992, 16, 11-18.
50. Torrance, G. W. Measurement of health state utilities for economic appraisal: A review. Journal of Health Economics, 1986, 5, 1-30.
51. Tunis, S. R., Bass, E. B., & Steinberg, E. The use of angioplasty, bypass surgery and amputation in the management of peripheral vascular disease. New England Journal of Medicine, 1991, 325, 556-62.
52. Veith, F. J., Gupta, S. K., Wengerter, K. R., et al. Changing arteriosclerotic disease patterns and management strategies in lower-limb-threatening ischemia. Annals of Surgery, 1990, 212, 402-14.
53. Ware, J. E., & Donald Sherbourne, C. The MOS 36-item short form health survey (SF36), 1. Conceptual framework and item selection. Medical Care, 1992, 30, 473-83.
54. Weinstein, M. C., Fineberg, H. V., & Jones, A. Clinical decision analysis, Philadelphia: W. B. Saunders Company, 1980.
55. Weinstein, M. C., & Stason, W. B. Foundations of cost-effectiveness analysis for health and medical practices. New England Journal of Medicine, 1977.
56. Williams, A. Economics of coronary artery bypass grafting. British Medical Journal, 1985, 291, 326-29.